Perimenopause and Menopause
Is Neurofeedback Safe during Perimenopause?
Individuals who are born female have a unique biological makeup. While hormones are crucial for creating life, hormones support our bodies in a myriad of ways, mental health included. In my practice in recent years, I have begun asking my Neurofeedback and counseling clients about their cycles in part to gain the broadest picture of their current circumstances. Perimenopause and Menopause are a unique time in a woman’s life that carries broader implications. Women deserve to be heard so we can find the care they need and deserve. Let’s dive a little deeper into the research and learn how Neurofeedback might be a tool for managing symptoms.
Peri/Menopause Symptoms
Around 50 million women annually enter menopause (no period for 12 consecutive months) demonstrating the prevalence of this expected, yet challenging life transition (Massart et al., 2001). Perimenopause (the time leading up to menopause) is triggered when estrogen and progesterone levels begin to fluctuate erratically (Let’s Talk Menopause). On average, women begin to experience symptoms around 50 years old, some even earlier. The onset of symptoms can vary due to culture, family history, social background as well as overall health and well-being (Parazzini, 2006; Hu et al., 1999). The National Institute of Aging states perimenopause symptoms are reported to last around 2-8 years depending on genetics, ethnicity, culture, lifestyle and environment (National Institute on Aging, 2024).
Menopause symptoms can be diverse: hot flashes, night sweat, vaginal dryness, sleep disturbance, depression, anxiety, memory loss, fatigue, concentration disorder, mood changes, headache, joint pains and weight gain (Makara-Studzińśka et al., 2014). The loss of estrogen can impact brain function (Morrison et al., 2006) resulting in symptoms that appear neurological in nature. The brain controls the release of estrogen, and several regions of the brain respond to estrogen including the hypothalamus, the neocortex, the hippocampus and the brainstem, and this is where Neurofeedback comes into play.
What is Neurofeedback?
Neurofeedback measures the brain’s electrical activity using sensors placed on the scalp. These sensors only read brain wave activity. It’s no different than a thermometer reading your temperature or a blood pressure cuff taking your blood pressure. The sensors do not send anything to the brain. There is no electrical current delivered to your head. There are no needles, no invasive procedures, no drugs, and no anesthesia.
Neurofeedback positively rewards the brain through visual or auditory feedback. When brainwaves are more regulated, the brain is rewarded. The brain needs information about its functioning in order to change. Consistent training teaches the brain to utilize regulated patterns thus reducing symptoms.
Other brain-based interventions like transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS) are fundamentally different because they stimulate the brain. Those carry their own safety profiles and considerations. Neurofeedback does not involve these mechanisms because there is no transmission into the brain.
Neurofeedback Research + Peri/Menopause Symptoms
Neurofeedback has been around since the 1960’s with a significant amount of research to support its efficacy. While there is not a great deal of Neurofeedback research specific to perimenopause/menopause, there is a great deal of research around many of the common symptoms related to perimenopause/menopause.
Hammond’s review on anxiety and depression highlighted Neurofeedback’s positive impact on these conditions (Hammond, 2005). Lambert-Beaudet’s non-systematic review cites encouraging results for insomnia (Lambert-Beaudet, 2021). Tegeler’s study, used a form of neuromodulation called HIRREM, found a decrease in hot flash frequency/severity and a decrease in symptoms of insomnia and depression (Tegeler, 2015).
Considering profound diseases like dementia and Alzheimer’s, it makes sense that women would be concerned about memory issues. The Study of Women’s Health Across the Nation (SWAN) found perimenopause was associated with a temporary decline in learning and memory scores, but these scores rebounded after menopause (Greendale, 2009). Cleveland Clinic experts explain how menopause memory changes differ from dementia. Menopause-related brain fog tends to stay stable or improve, while dementia tends to progress. Alzheimer’s disease mainly affects people over age 65 (Cleveland Clinic, 2025).
The International Society for Neuroregulation and Research (ISNR) has a comprehensive list of Neurofeedback research.
The Bottom Line
Neurofeedback can be an excellent adjunctive therapy to support women through this transition. Neurofeedback is noninvasive, drug-free and hormone free. Generally speaking, Neurofeedback is safe for most individuals. Neurofeedback reviews consistently find that serious adverse effects aren’t typical, it is generally safe to use with other treatments, and there are no restrictions specific to perimenopause in the research. Every client’s situation is unique so be sure to speak with your physician if you have any questions or concerns. While side effects tend to be minor, temporary, and manageable, they are not reasons to avoid seeking care; it is important to be aware of them and discuss any concerns with your Neurofeedback practitioner.
Neurofeedback is a non-pharmacological tool which trains the brain toward greater stability, resilience, and self-regulation without adding more chemical changes to an already shifting hormonal landscape.
Have more Questions?
If you’re considering neurofeedback during perimenopause or menopause, we’re happy to answer your questions, talk through your personal experience and explain the process so you can make an informed decision for your needs. Our clinician, Tiffany Cagle-Schrift, is a licensed mental health provider who is board certified in Neurofeedback and QEEG. Tiffany has been in the mental health field since 2012.
Contact A Brighter Mind to schedule your complementary 30-minute consultation to learn more about our approach to supporting brain health during the menopausal transition.
Sources:
Cleveland Clinic. (2025, March 5). Menopause Memory Loss: Should You Be Worried? Health Essentials. https://health.clevelandclinic.org/memory-loss-in-middle-aged-women-is-it-age-or-menopause.
Greendale, G.A., et al. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology.72(21):1850-7. doi:10.1212/WNL.0b013e3181a71193.
Hammond, D. C. (2005). Neurofeedback treatment of depression and anxiety. Journal of Adult Development, 12(2–3), 131–137. https://doi.org/10.1007/s10804-005-7029-5.
Hu, F. B., Grodstein, F., Hennekens, C. H., Colditz, G. A., Johnson, M., Manson, J. E., Rosner, B., & Stampfer, M. J. (1999). Age at natural menopause and risk of cardiovascular disease. Archives of Internal Medicine, 159(10), 1061. https://doi.org/10.1001/archinte.159.10.1061.
Lambert-Beaudet, F., et al. (2021). Neurofeedback for insomnia: Current state of research. World J Psychiatry. 11(10):897–914. doi: 10.5498/wjp.v11.i10.897.
Let’s Talk Menopause. What is Menopause? https://www.letstalkmenopause.org/what-to-know.
Makara-Studzińśka, M. T., Kryś-Noszczyk, K. M., & Jakiel, G. (2014). Epidemiology of the symptoms of menopause – an intercontinental review. Menopausal Review, 3, 203–211. https://doi.org/10.5114/pm.2014.43827.
Massart, F., Reginster, J. Y., & Brandi, M. L. (2001). Genetics of menopause-associated diseases. Maturitas, 40(2), 103–116. https://doi.org/10.1016/s0378-5122(01)00283-3.
Morrison, J. H., Brinton, R. D., Schmidt, P. J., & Gore, A. C. (2006). Estrogen, menopause, and the aging brain: How basic neuroscience can inform hormone therapy in women. Journal of Neuroscience, 26(41), 10332–10348. https://doi.org/10.1523/jneurosci.3369-06.2006.
Parazzini, F. (2006). Determinants of age at menopause in women attending menopause clinics in Italy. Maturitas, 56(3), 280–287. https://doi.org/10.1016/j.maturitas.2006.09.003.
Tegeler, C.H., et al. (2015). Reduction in menopause-related symptoms associated with use of a noninvasive neurotechnology for autocalibration of neural oscillations. Menopause. 22(6):650–655. doi: 10.1097/GME.0000000000000422.
This article is for informational purposes only and does not constitute medical advice. If you are considering neurofeedback during perimenopause or menopause, discuss it with your healthcare provider and a qualified neurofeedback practitioner.
At A Brighter Mind, every new client relationship begins with an initial consultation with our board-certified clinician Tiffany Cagle-Schrift.
Schedule your consultation today!